secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2026-05-21T20:10:15+00:00
Accession:  0001193125-26-234419
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio changes fiscal year-end from Dec 31 to June 30, effective July 1, 2026
--------------------------------------------------------------------------------

- Board approved fiscal year change from December 31 to June 30, effective July 1, 2026.
- Company will file a transition report on Form 10-KT for the six-month period Jan 1, 2026 to June 30, 2026.
- Quarterly reports will follow new fiscal year, beginning with the quarter ending September 30, 2026.
- Change is effective for the company's next fiscal year starting July 1, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000119312526234419/0001193125-26-234419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000119312526234419/anab-20260518.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-234419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer